Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
Rangering i aksjer #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Aksjekurs
$1.58
Sist synkronisert: 2026-08-21
Markedsverdi
$71.95M
Endring (1 dag)
0.64%
Endring (1 år)
-36.29%
Land
US
Handel OS Therapies Incorporated (OSTX)

Kategori

P/B-forhold for OS Therapies Incorporated (OSTX)
P/B-forhold per 2026 TTM: 0
Ifølge OS Therapies Incorporated sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for OS Therapies Incorporated fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH